Roles of nuclear receptors in the gene expression of drug-metabolizing enzymes under various physiological conditions

被引:2
|
作者
Yoshinari, Kouichi [1 ]
机构
[1] Univ Shizuoka, Sch Pharmaceut Sci, Dept Pharmacobiochem, Suruga Ku, Shizuoka 4228526, Japan
关键词
cytochrome P450; nuclear receptor; constitutive androstane receptor; model animal; nuclear translocation; obesity;
D O I
10.1248/yakushi.126.343
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The nuclear receptor constitutive androstane receptor (CAR), a key transcription factor for the expression of cytochrome P450 (CYP) 2B genes, resides in the cytoplasm under untreated conditions and translocates into the nucleus upon xenobiotic exposure. CAR forms a multiprotein complex including heat shock protein 90 in the cytoplasm as the glucocorticoid receptor, and it is likely that protein phosphatase 2A plays a critical role in the first step of CAR nuclear translocation. In addition to the xenobiotic induction of CYP2Bs, our recent studies have indicated that CAR is important for sex and strain differences and obesity/ diabetes-associated changes in the expression of CYP2B genes. These results have raised the hypothesis that the expression of nuclear receptors varies depending on the physiologic condition, leading to the dysregulation of CYP expression. In obese mice fed a high-fat diet, however, hepatic CYP3A levels are drastically decreased without any significant changes in the expression of nuclear receptors including the pregnane X receptor and hepatocyte nuclear factor-4, which are known to be key transcription factors in the expression of CYP3A genes. These results indicate that it is important to investigate the mechanism of the transcriptional regulation of nuclear receptor genes as well as the activation of nuclear receptors to understand the CYP expression system fully.
引用
收藏
页码:343 / 348
页数:6
相关论文
共 50 条
  • [1] Polymorphisms of human nuclear receptors that control expression of drug-metabolizing enzymes
    Okey, AB
    Boutros, PC
    Harper, PA
    PHARMACOGENETICS AND GENOMICS, 2005, 15 (06): : 371 - 379
  • [2] Expression of drug-metabolizing enzymes
    Guengerich, FP
    Parikh, A
    CURRENT OPINION IN BIOTECHNOLOGY, 1997, 8 (05) : 623 - 628
  • [3] Epigenetic Changes in Gene Expression for Drug-Metabolizing Enzymes and Transporters
    Kim, In-Wha
    Han, Nayoung
    Burckart, Gilbert J.
    Oh, Jung Mi
    PHARMACOTHERAPY, 2014, 34 (02): : 140 - 150
  • [4] Nuclear receptors in the multidrug resistance through the regulation of drug-metabolizing enzymes and drug transporters
    Chen, Yakun
    Tang, Yong
    Guo, Changxiong
    Wang, Jiuhui
    Boral, Debasish
    Nie, Daotai
    BIOCHEMICAL PHARMACOLOGY, 2012, 83 (08) : 1112 - 1126
  • [5] Drug-metabolizing enzymes and transporters: Expression in the human prostate and roles in prostate drug disposition
    Obligacion, R
    Murray, M
    Ramzan, I
    JOURNAL OF ANDROLOGY, 2006, 27 (02): : 138 - 150
  • [6] Impact of obese levels on the hepatic expression of nuclear receptors and drug-metabolizing enzymes in adult and offspring mice
    Pei Wang
    Xueyan Shao
    Yifan Bao
    Junjie Zhu
    Liming Chen
    Lirong Zhang
    Xiaochao Ma
    Xiao-bo Zhong
    Acta Pharmaceutica Sinica B, 2020, 10 (01) : 171 - 185
  • [7] Impact of obese levels on the hepatic expression of nuclear receptors and drug-metabolizing enzymes in adult and offspring mice
    Wang, Pei
    Shao, Xueyan
    Bao, Yifan
    Zhu, Junjie
    Chen, Liming
    Zhang, Lirong
    Ma, Xiaochao
    Zhong, Xiao-bo
    ACTA PHARMACEUTICA SINICA B, 2020, 10 (01) : 171 - 185
  • [8] Heterologous expression of human drug-metabolizing enzymes
    Guengerich, FP
    Parikh, A
    Johnson, EF
    Richardson, TH
    VonWachenfeldt, C
    Cosme, J
    Jung, F
    Strassburg, CP
    Manns, MP
    Tukey, RH
    Pritchard, M
    FournelGigleux, S
    Burchell, B
    DRUG METABOLISM AND DISPOSITION, 1997, 25 (11) : 1234 - 1241
  • [9] Nuclear receptors and drug metabolizing enzymes
    Maurel, Patrick J.
    Gerbal-Chaloin, Sabine
    Duret, Cedric
    Pascussi, Jean-Marc
    Vilarem, Marie-Jose
    Pichard-Garcia, Lydiane
    Daujat-Chavanieu, Martine
    DRUG METABOLISM REVIEWS, 2006, 38 : 6 - 7
  • [10] The effects of culture conditions on the expression of drug-metabolizing enzymes in primary human hepatocytes
    Hamilton, GA
    Laethem, RM
    Jolley, SL
    Gilbert, D
    Coon, DJ
    Webster, L
    LeCluyse, EL
    DRUG METABOLISM REVIEWS, 2002, 34 : 103 - 103